Cardlytics
CDLX
124 hedge funds and large institutions have $279M invested in Cardlytics in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 15 closing their positions.
93% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 15
22% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 37
11% more funds holding
Funds holding: 112 → 124 (+12)
0.29% more ownership
Funds ownership: 7.43% → 7.73% (+0.29%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
40% less capital invested
Capital invested by funds: $463M → $279M (-$184M)
40% less call options, than puts
Call options by funds: $6.27M | Put options by funds: $10.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$15.3M |
| 2 |
DKCM
Davidson Kempner Capital Management
New York
|
+$3.2M |
| 3 |
BCM
Brightlight Capital Management
Westport,
Connecticut
|
+$3.12M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.01M |
| 5 |
BlackRock
New York
|
+$2.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.74M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$5.26M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$4.35M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.76M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.35M |
CDLX Hedge Fund Activity: Q4 2023 in Review
124 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2023, worth a combined $279M — down 40% from $463M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CDLX positions and 15 closed out — a net gain of 14 holders — while 45 added to existing stakes and 37 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $15.3M. The largest seller was Invesco, cutting an estimated $6.74M.
- 124 institutional investors held Cardlytics (CDLX) as of Q4 2023, up from 112 in Q3 2023.
- Funds reported $279M of Cardlytics stock for Q4 2023, down 40% quarter-over-quarter.
- 29 funds opened new Cardlytics positions in Q4 2023 and 15 closed out, a net change of +14 holders.
- The largest Cardlytics buyer in Q4 2023 was Morgan Stanley, an estimated $15.3M added.
- The largest Cardlytics seller in Q4 2023 was Invesco, an estimated $6.74M sold.
Based on aggregated 13F filings for Q4 2023.